COVID-19 update: India's new cases fall below 10,000 for second time in February

The number of people who have recuperated from the disease surged to 1,05,48,521 pushing the national COVID-19 recovery rate to 97.25 percent, while the COVID-19 case fatality rate stands at 1.43 percent.

PTI

February 09, 2021 / 12:07 IST

The daily new COVID-19 cases fell below 10,000 for the second time this month taking India’s tally of cases to 1,08,47,304, while fresh fatalities remained below 100 for the fourth consecutive day, according to the Union Health Ministry data updated on Tuesday.

A total of 9,110 new infections were reported in a span of 24 hours.

The death toll increased to 1,55,158 with 78 daily new fatalities, the data updated at 8 am showed.

The number of people who have recuperated from the disease surged to 1,05,48,521 pushing the national COVID-19 recovery rate to 97.25 percent, while the COVID-19 case fatality rate stands at 1.43 percent.

The COVID-19 active caseload remained below 2 lakh.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show

COVID-19 update: India's new cases fall below 10,000 for second time in February

The number of people who have recuperated from the disease surged to 1,05,48,521 pushing the national COVID-19 recovery rate to 97.25 percent, while the COVID-19 case fatality rate stands at 1.43 percent.

Related stories

Subscribe to Tech Newsletters

COVID-19 update: India's new cases fall below 10,000 for second time in February

The number of people who have recuperated from the disease surged to 1,05,48,521 pushing the national COVID-19 recovery rate to 97.25 percent, while the COVID-19 case fatality rate stands at 1.43 percent.

Related stories

Subscribe to Tech Newsletters

Trending news